Use the Back button in your browser to see the other results of your search or to select another record.
Exercise intensity and markers of inflammation during and after (neo-)adjuvant cancer treatment |
Schauer T, Mazzoni A-S, Henriksson A, Demmelmaier I, Berntsen S, Raastad T, Nordin K, Pedersen BK, Christensen JF |
Endocrine-Related Cancer 2021 Mar;28(3):191-201 |
clinical trial |
7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: No; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|